Literature DB >> 29990979

Gene Therapy and Virotherapy of Gliomas.

Julius W Kim, Alan L Chang, J Robert Kane, Jacob S Young, Jian Qiao, Maciej S Lesniak.   

Abstract

Despite many recent advances in the management of gliomas, such as aggressive surgical resection, chemoradiotherapy, antiangiogenic therapy, and molecular targeted therapy, the survival of patients with high-grade neoplasms remains dismal. Gene therapy and oncolytic virotherapy have emerged as highly promising strategies for treatment of malignant brain tumors due to recent progress in understanding of the underlying cancer biology as well as improved techniques for genetic modification of potential therapeutics.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2018        PMID: 29990979     DOI: 10.1159/000469685

Source DB:  PubMed          Journal:  Prog Neurol Surg        ISSN: 0079-6492


  2 in total

1.  Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.

Authors:  Lingyang Xia; Peng Jin; Wei Tian; Shuang Liang; Liye Tan; Binxin Li
Journal:  Braz J Med Biol Res       Date:  2021-05-17       Impact factor: 2.590

2.  CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p.

Authors:  Kebin Zheng; Haipeng Xie; Wensong Wu; Xichao Wen; Zhaomu Zeng; Yanfang Shi
Journal:  Cancer Cell Int       Date:  2021-01-07       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.